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Abstract
Nephrectomized rats have widely been used to study chronic renal failure. Interestingly, renal cell carcinoma occurred
in the remnant kidney after uninephrectomy (UNX). In this study, we probed insulin-like growth factor (IGF)-1 signaling
pathway in UNX-induced renal cancer. Adult male Sprague-Dawley rats were randomized into two groups: UNX rats
(n= 22) and sham-operated rats (n= 12). Rats were killed at 3, 7, and 10 months. After 7 months after nephrectomy,
the UNX rats developed renal cell carcinomawith increased expression of proliferating cell nuclear antigen, and 68.2%
(15/22) of the animals exhibited invasive carcinoma. Western blot demonstrated significant down-regulation of IGF
binding protein 3 contrasting with the up-regulation of protein kinase Cζ and Akt/protein kinase B in the renal cancer
tissues. These findings indicate a unique rat model of UNX-induced renal cancer associated with enhanced IGF-1 sig-
naling pathway.
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Introduction
Nephrectomized animal models have widely been used in studies of
high blood pressure [1,2] and renal dysfunction [3]. Interestingly, we
found renal cell carcinoma in uninephrectomized (UNX) rats un-
expectedly. However, the molecular mechanism underlying the renal
cancer is unknown. Previous studies suggested that carcinogenesis
linked to insulin-like growth factor-1 (IGF-1) signaling pathway. Key
IGF-1 signaling molecules such as IGF binding protein 3 (IGFBP-3),
Akt/protein kinase B (PKB) and protein kinase C (PKC) ζ contribute
to malignant transformation of proliferating cells and promote cancer
cell growth and invasion.
IGF-1 has long been recognized to play an important role in cell
growth and carcinogenesis [4]. Elevated blood IGF-1 level was reported
in previous studies during compensatory renal growth in unilateral or
subtotal nephrectomized human subjects and animals [5,6]. Further-
more, administration of IGF-1 was found to stimulate early growth of
renal cell carcinoma in vivo [7]. Conversely, cancer growth stimulated by
IGF-1 is associated with a low level of IGF-1 binding proteins (IGFBPs)
[8]. Among the IGFBPs, IGFBP-3 is identified for its inhibitory effects
on cancer growth. Reduction in IGFBP-3 levels contributes to un-
controlled cell growth by increasing IGF bioavailability and diminishing
its inhibitory effect on the IGF pathway. Indeed, lower IGFBP-3 level is
linked to increased risk of relapse and unfavorable prognosis in patients
with different types of cancers [9,10]. The cancer-promoting effects of
IGF are mediated by the phosphoinositide 3-kinase (PI3K) signaling
pathway [4], in which Akt/PKB has been well recognized for its tumor-
stimulating effects by enhancing protein synthesis and suppressing
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apoptosis [11]. Similarly, PKCζ of the PI3K signaling pathway is
another key molecule in cancer biology [12]. Activation of PKCζ
has been found to stimulate protein synthesis [12] and mediate cell
proliferation, cell survival, cell migration, and angiogenesis during
cancer progression [13].
Cancer growth is characterized by uncontrolled cell proliferation.
Proliferating cell nuclear antigen (PCNA) is a key protein expressed in
the nuclei of actively dividing cells during the DNA synthesis phase of
the cell cycle [14]. PCNA is involved in a wide range of cellular functions
including DNA replication, repair, and epigenetic maintenance [15].
PCNA level in cancer cells is usually several-fold higher than those in
normal cells [16]. Clinically, PCNA serves as a general proliferative
marker, especially in predicting prognosis of cancer progression and me-
tastasis [17]. In this study, we probed the protein expression levels of
PCNA, IGFBP-3, PKCζ, and Akt/PKB in UNX-induced renal cancer
to reveal the role of the IGF-1 signaling pathway in renal carcinogenesis.
Materials and Methods
Experiments were performed under the Animals (Control of Experi-
ments) Ordinance and received the approval of Animal Research Ethics
Committee of Hong Kong.
Animals
Three-month-old male Sprague-Dawley rats between 250 and 300 g
were obtained from the Laboratory Animal Services Centre at the
Chinese University of Hong Kong. The animals were caged in pairs,
housed at 23 ± 1°C with artificial lights on from 6:00 AM to 6:00 PM,
and had free access to water and standard laboratory rat diet (5001
Rodent Diet; LabDiet America, St Louis, MO). Rats were randomized
into either left nephrectomy (UNX, n = 22) or sham operation (sham,
n = 12). At 3 months after operation, 2 rats from each group were killed
for histologic assessment of renal cancer, whereas 10 UNX and 5 sham
rats were killed at 7 and 10months after operation. The total duration of
observation was 10 months.
Unilateral Nephrectomy
Rats were anesthetized with ketamine (75 mg/kg; Alfasan, Woerden,
the Netherlands) and xylazine (10 mg/kg; Alfasan). The left kidney was
exposed through left flank incision and was removed, leaving the adre-
nal gland intact in the abdominal cavity. Sham-operated rats underwent
anesthesia and ventral laparotomy without removal of the left kidney.
After surgery, animals were recovered from anesthesia under a heating
lamp with food and water freely available.
Metabolic and Biochemical Studies
Body weight and daily intake of water and food were monitored
monthly. Eight-hour fasting blood samples for sera preparation were
collected by cardiac puncture when the rats were killed. Fasting blood
samples were sent to the Department of Chemical Pathology in the
Prince of Wales Hospital for the measurement of renal function. Serum
urea was measured by enzymatic method using a Modular Analytics
analyzer (Roche Diagnostics GmbH, Mannheim, Germany).
Histologic Studies of Kidneys
Rats were longitudinally killed at 3, 7, or 10 months after operation.
Kidneys from all the rats were removed, weighted, and processed for
light microscopy. Tissue samples were fixed in 10% neutral formalde-
hyde and embedded in paraffin. Serial longitudinal sections (4 μm)
were spliced parallel to the longest axis of the kidney and stained with
periodic acid–Schiff. Stained slides were examined with a Zeiss Axio-
plan 2 imaging microscope (Carl Zeiss, Inc, Hamburg, Germany),
and representative images were captured using a SPOT digital camera
(Diagnostic Instruments, Inc, Sterling Heights, MI).
Western Blot Assays
Tissue total proteins from renal cortex were extracted. Briefly, tissue
was homogenized in a buffer containing 50 mM Tris-HCl (pH 7.4),
150 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 1 mM EDTA,
1% sodium deoxycholate, 1% Triton X-100, 1% sodium dodecyl
sulfate, and 5% protease inhibitor cocktail (catalog no. P2714; Sigma,
St Louis, MO). The homogenate was centrifuged at 13,000 rpm
for 10 minutes at 4°C. The resulting supernatant was removed, and
protein concentrations in the supernatant were determined by the
BCA Protein Assay Kit (ThermoFisher Scientific, Waltham, MA).
Tissue lysates (100 μg) and prestained molecular weight markers
(Bio-Rad, Hercules, CA) were loaded onto sodium dodecyl sulfate–
polyacrylamide electrophoresis gels with 4% acrylamide stacking gel
and 10% running gel. The resolved proteins were then transferred onto
nitrocellulose membranes. The membranes were blocked for 1 hour at
room temperature with 5% skimmed milk, incubated with primary
antibodies of IGFBP-3 (dilution 1:1000; Santa Cruz Biotechnology,
Figure 1. Gross examination of the remnant kidney in UNX rats.
(A) UNX rats exhibited a enlarged granular, grayish remnant kidney.
(B) Cross-sectional view of the remnant kidney in UNX rats demon-
strates diffuse thickening of cortex. (C) Sham rats showed a smooth,
reddish right kidney. (D) Cross-sectional view of the right kidney in
sham rats demonstrates lighter cortex and darker medulla.
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Santa Cruz, CA), Akt1/2/3 (dilution 1:1000; Cell Signaling Tech-
nology, Danvers, MA), PKCζ (dilution 1:1000; Santa Cruz Biotech-
nology), and mouse anti-PCNA (dilution 1:1000; Dako, Carpinteria,
CA) in TBS containing 0.05% Tween 20 (TBS-T) with 5% skimmed
milk overnight at 4°C. After washing with TBS-T, membranes were
incubated with antigoat, antirabbit, or antimouse secondary antibody
conjugated to horseradish peroxidase (Upstate, Temecula, MA) with
dilution of 1:2000. Proteins were detected by enhanced chemilumines-
cence (Amersham, Piscataway, NJ) on Hyperfilm. The major protein
bands with approximately 42 kDa for IGFBP-3, 60 kDa for Akt1/2/
3, 80 kDa for PKCζ, and 30 kDa for PCNA were detected. To ensure
equal loading of proteins, membranes were incubated and probed with
a rabbit anti–β-actin antibody (Abcam, Cambridge, MA) with dilution
of 1:10,000, which recognizes β-actin at approximately 43 kDa. Signals
were quantitated by densitometry and corrected for the β-actin signal,
using the Kodak Digital Image station 440CF and the ID Image Anal-
ysis software program (Kodak, Rochester, NY).
Statistical Analysis
Data are mean ± SD unless specified. The statistical significance of
difference noted in the biochemical parameters was evaluated using
2-tailed t-test or Mann-Whitney U test. P < .05 was taken as criterion
for a statistically significant difference.
Results
Carcinogenesis of Remnant Kidneys
Grossly, UNX rats showed a double-sized remnant kidney (4.5 ±
0.9 vs 2.1 ± 0.2 g in sham rats, P < .001) with pallor, grainy surface (Fig-
ure 1). The remnant kidneys with cancer showed diffuse thickening of
renal cortex in longitudinal sections (Figure 1, A and B). In sham rats,
the remnant kidneys were reddish with lighter outer cortex and darker
medulla (Figure 1, C and D).
A spectrum of renal carcinogenesis from neoplastic proliferation of
tubular epithelial cells to invasive carcinoma was observed by longi-
tudinally microscopic examination of the remnant kidneys (Figure 2).
At 3 months after operation, microscopic examination revealed glo-
merular hypertrophy and tubular cell neogenesis without malignant
transformation in the remnant kidney (Figure 2A). At 7 months after
operation, renal cell carcinoma was found in 7 of 10 UNX rats killed
at this time point (Figure 2B). At 10 months after operation, renal
cell carcinoma was found in 8 of 10 UNX rats (Figure 2C ). In con-
trast, sham rats showed normal renal structure during the observation
period (Figure 2D). The cancer lesions in the remnant kidneys in-
cluded neoplastic proliferation of tubular epithelial cells (Figure 3A),
in situ carcinoma (Figure 3B, inset), invasive carcinoma with central
necrosis, and invasion of nonneoplastic tubules (Figure 3C , inset).
Malignant transformation of renal cell nuclei was found in parallel
to the neogenesis and carcinogenesis in the remnant kidney of UNX
rats (Figure 4). At 10 months after nephrectomy, tubular cell apopto-
sis as evident by extensive apoptotic bodies and nuclear condensation
were seen in renal tubules (Figure 4A). Simultaneously, cell prolifer-
ation as evident by increased mitotic figures (mitosis) and tubular cell
neogenesis (Figure 4B) was frequently observed. Histopathologic
characteristics of renal cell carcinoma in the UNX rats included bizarre
nuclei, frequent mitosis, and tissue invasion (Figure 4C ). In agreement
with the histopathologic observation, Western blot revealed a four-fold
increase of PCNA protein expression in the remnant kidneys with car-
cinoma (Figure 4D).
Figure 2. Development of renal cell carcinoma in the remnant kidney ofUNX rats. (A) At 3months after nephrectomy, UNX rats demonstrated
glomerular hypertrophy but not malignancy. (B) At 7 months after nephrectomy, UNX rats showed malignant transformation of tubular epi-
thelial cells in parallel to diffuse glomerulosclerosis. (C) At 10 months after nephrectomy, UNX rats showed nests of renal cell carcinoma in
parallel to global glomerulosclerosis. (D) Sham rats at 10 months after operation revealed normal renal structure.
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Protein Expression Levels of IGF Signaling Pathway
Protein expression levels of IGF signalingmolecules such as IGFBP-3,
Akt/PKB, and PKCζ were measured by Western blot. The detected
protein levels were normalized to the expression level of β-actin and then
adjusted to the corresponding quantities in sham rats (Figure 5). In the
remnant kidneys of UNX rats, protein expression of the growth inhibi-
tory factor IGFBP-3 was significantly reduced approximately to 50%
(Figure 5, A and B). In contrast, protein expression levels of growth-
promoting factors Akt/PKB and PKCζ in the remnant kidneys of the
UNX rats were significantly increased (Figure 5, A, C , and D). These
findings indicated down-regulation of IGFBP-3 protein expression
coupled with up-regulation of Akt and PKCζ in the remnant kidneys
with cancer.
Uninephrectomy-Induced Renal Impairment
In this study, fasting serum urea and creatinine levels at 10 months
after operation were measured to reflect renal function. Compared
with sham-operated rats, UNX rats had significantly higher serum urea
Figure 3.Morphology of carcinogenesis in the remnant kidneys of
UNX rats at 10 months after nephrectomy. (A) Neoplastic prolifera-
tion of tubular epithelial cells. (B) In situ carcinoma (inset). (C) Invasive
carcinoma with central necrosis (inset) and invasion of nonneoplas-
tic tubules.
Figure 4. Apoptosis, neogenesis, carcinogenesis, and protein ex-
pression of PCNA in the remnant kidneys of UNX rats at 10 months.
(A) Tubular cell apoptosis as evident by apoptotic bodies (circles) and
nuclear condensation (arrows). (B) Tubular cell neogenesis as evi-
dent bymitotic figures (circles). (C) Renal cell carcinoma is character-
ized by tissue invasion and bizarre nucleation. Protein abundance of
PCNA was four-fold high in the remnant kidney with cancer in UNX
rats. Data are mean ± SD; †P < .05 versus sham rats.
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(19.6 ± 7.3 vs 7.0 ± 1.9 mM, P < .001) and creatinine (98.5 ± 25.5 vs
42.9 ± 9.8 μM, P < .001). Body weight (564 ± 49 vs 593 ± 42 g, P =
.225) and daily food consumption (34 ± 6 vs 33 ± 5 g, P = .723) were
similar between the UNX rats and sham rats, whereas UNX rats had
more water consumption (73 ± 9 vs 41 ± 7ml, P < .001) than sham rats.
Discussion
In this report, we longitudinally described the development and pro-
gression of renal cell carcinoma in the remnant kidneys of UNX rats.
Molecular mechanisms underlying the renal carcinogenesis focus on
the IGF signaling pathway involving key molecules such as IGFBP-3,
Akt/PKB, and PKCζ.
Elevation of renal tissue IGF-1 is associated with the enlargement of
remnant kidney in UNX rats [18]. Renal mass loss, as induced by UNX
in this study, may stimulate IGF-1 production and diminish IGF-1
degradation and excretion from the remnant kidney, thus, consequently,
augments local and systemic IGF-1 levels. In this regard, IGF-1 can be
both a cause and a consequence of compensatory renal growth. Al-
though renal IGF-1 levels were not measured in this study, a two-fold
enlargement of remnant kidneys in UNX rats compared with the cor-
responding right kidneys in sham-operated rats was observed in previous
study [19]. Hence, it is possible that the increased Akt/PKB and PKCζ
expression may result from the activated receptors of growth factors in-
cluding IGF-1 and insulin that are required by the compensatory renal
cell hyperplasia and proliferation. Therefore, normal IGF-1 signaling
pathway such as the regulation of IGF-1 by IGFBP-3 in normal renal
tissue might be disturbed in the remnant kidneys of UNX rats.
The PI3K/Akt pathway is believed to be an important cellular adap-
tation toward cell growth and malignant transformation. It has been
shown that activation of Akt/PKB is tumor-specific [20] and that the
PI3K/Akt pathway is constitutively activated in human cancers of several
organs including ovary, prostate, and lung [21]. Elevation of Akt/PKB
has been reported in several human renal cell carcinoma cell lines, indi-
cating a constitutive activation of Akt/PKB in the pathogenesis of
human renal cell carcinoma [20]. Our findings showed an elevated level
of Akt/PKB in the remnant kidneys with cancer, suggesting that the
PI3K/Akt signaling pathway is common to renal cell carcinogenesis
in vivo. However, growth inhibition of cancer cells by the inhibitors of
PI3K and Akt/PKB is not complete even at high concentrations [20],
indicating that other growth/survival pathways also play a role in the
development of renal cell carcinoma.
High incidence of cancer was noticed in human kidney transplant
recipients. In a retrospective study, renal transplant recipients were
found to have a 4.3 times higher risk of developing any type of cancers
including renal cancer, compared with an age- and sex-matched popu-
lation of the same geographical area [22]. Increased risk of cancer was
also reported in Australian [23] and French [24] people who underwent
Figure 5. Expression of IGFBP-3, Akt/PKB, and PKCζ by Western
blot. Renal tissue specimens were obtained from sham and UNX
rats after 10 months after operation. Protein expression of IGFBP-3
reduced approximately 50% (panels A and B), whereas protein
abundance of Akt/PKB (panels A and C) and PKCζ was increased
(panels A and D). Data are mean ± SD; †P < .05 versus sham rats.
Figure 6. Proposed IGF-1 signaling pathway in renal carcinogenesis
induced by uninephrectomy. Down-regulation of IGFBP-3 in IGF-1
signaling pathway contrasting with up-regulation of Akt/PKB and
PKCζ expression may enhance cell proliferation, malignant transfor-
mation, cancer growth, and invasion.
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renal transplantation. In contrast, only a two-fold increased incidence
for some of the most common tumors in the general population, such
as lung or colorectal cancers, was found in the kidney transplant recipi-
ents [22]. In addition to immunosuppression that predisposes to viral
carcinogenesis, compensatory renal allograft growth associated with
abnormal IGF-1 signaling pathway might be crucial. Interestingly, sev-
eral clinical trials on renal transplant recipients revealed that therapies
based on inhibition of mammalian target of rapamycin, a crucial factor
activated by Akt/PKB in PI3K pathway, significantly reduced the risk
of developing any malignancy compared with all other immunosup-
pressive regimens [25,26]. This finding suggests a pivotal role of PI3K
pathway in the process of renal carcinogenesis.
One should be cautious in extrapolating from animal observations
to human disease because profound differences exist between humans
and rats. In this rodent study, most rats progressively developed chronic
renal impairment after UNX. In human kidney donors, renal function
test results are normal or only mildly impaired after uninephrectomy
[27–29]. Nevertheless, physiopathologic changes observed in this ani-
mal model can shed light on the area of cancer biology especially in
patients with chronic renal failure. In fact, a significant decrease in
glomerular filtration rate was found in human kidney donors and
other single-kidney survivors [30]. Long-term effects of kidney donation
and renal transplantation on cancer risk warrant decades of clinical
follow-up.
On the basis of the findings from this study, we propose a hypothesis
of renal carcinogenesis induced by uninephrectomy (Figure 6). Evidence
in this study suggests that IGF signaling pathway characterized by
decreased IGFBP-3 contrasting with increased Akt/PKB and PKCζ ex-
pression may stimulate cell malignant transformation from limited cell
proliferation, which may, in turn, predispose proliferating cells to cancer
cells. Currently unknown are the detailed expressions of each factor
mediating the process of malignant transformation. Clarification of
themolecular mechanisms in this process awaits additional investigation
and may be of value in cancer prevention and control.
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